`

Kymera Therapeutics

Biotechnology Research

Last Updated: November 24, 2025
Sign Up to View More
Revenue
$47.07M
funding-icon Total Funding
$275.0M
Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs
Recent News

Frequently Asked Questions About Kymera Therapeutics

What does Kymera therapeutics do?+

Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on delivering oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Kymera is also progressing degrader oncology programs that target undrugged or poorly drugged proteins to create new ways to fight...

What is Kymera therapeutics's industry? +

Kymera therapeutics operates in the Biotechnology research industry.

What is Kymera therapeutics's revenue? +

Kymera therapeutics's revenue is $47.07m

What is Kymera therapeutics's company size? +

Kymera therapeutics has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free